Current Research Studies

Cancer – AALL1521: Phase 2 Study of Ruxolitinib with Chemotherapy in Children with Acute Lymphoblastic Leukemia

Condition or Therapy:



Cancer and blood disorders
Study Number: AALL1521

What is the goal of this study?

Researchers want to study the combination of ruxolitinib with chemotherapy in the treatement of B-cell acute lymphoblastic leukemia.

Who can join the study?

This study may be a good fit for children and young adults who:

  • Are between 1 and 21 years old, and 
  • have been newly diagnosed with High-Risk, PH-like B-Accute Lymphoblastic Leukemia.

What will happen if my child takes part in this study?

You can read more about this study at

Who can I contact for more information?

For more information, call 206-987-2106 or send us an email.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Colleen Annesley